The trial results are critical, as it brings Eli Lilly's pill one step closer to becoming a new, needle-free alternative for ...

The increasing popularity of weight loss drugs like Wegovy, Ozempic, Mounjaro and metformin may have you wondering how all these options stack up.

Novo Nordisk already has a fairly well-stocked pipeline of candidates, but one of its near-term hopes – CagriSema, which ...

The licensing pact adds a second so-called "triple agonist" to the Danish drugmaker's portfolio as competition with Lilly and other contenders heats up.

The medical director of the NHS has warned of the side effects of weight loss drugs after figures revealed the number of deaths associated with the jabs ...

The active ingredient in Rybelsus and Ozempic, semaglutide, has shown effectiveness for weight loss in some people. However, neither Ozempic nor Rybelsus are FDA approved for this use. Another ...

While Medicare doesn’t currently cover Rybelsus for weight loss purposes, it may cover costs in the future. Medicare is reviewing its current antiobesity medication exclusions, which could mean ...

People using weight-loss injections are being warned of potential side effects that could impact their ability to drive ...

It seems like no matter what I do, I can’t lose weight. Most of my family members struggle with their weight too. Do our ...

Despite the current downward trend of NVO, it is a good stock to add to one's portfolio for long-term gains due to strong ...

Eli Lilly has launched its blockbuster diabetes and weight-loss drug Mounjaro in India following approval from the country’s ...